ocrelizumab and hyaluronidase

FDA Drug Profile — Ocrevus Zunovo

ocrelizumab and hyaluronidase is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Ocrevus Zunovo. Available dosage form: injection, solution.

Drug details

Generic Name
ocrelizumab and hyaluronidase
Brand Names
Ocrevus Zunovo
Application Number
BLA761371
Sponsor
Genentech, Inc.
NDC Codes
3
Dosage Forms
INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
OCRELIZUMAB, HYALURONIDASE (HUMAN RECOMBINANT)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.